{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:36:16Z","timestamp":1790746576044,"version":"4.1.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002261","name":"Russian Foundation for Basic Research","doi-asserted-by":"publisher","award":["19-015-00345"],"award-info":[{"award-number":["19-015-00345"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Xenon (Xe) is a noble gas that has been used for the last several decades as an anesthetic during surgery. Its antagonistic effect on glutamate subtype of NMDA (<jats:italic>N<\/jats:italic>-methyl-<jats:sc>d<\/jats:sc>-aspartate) receptors resulted in evaluation of this gas for treatment of CNS pathologies, including psychoemotional disorders. The aim of this study was to assess the behavioral effects of acute inhalation of subanesthetic concentrations of Xe and to study the outcomes of Xe exposure in valproic acid (VPA)-induced rodent model of autism.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We have conducted two series of experiments with a battery of behavioral tests aimed to evaluate locomotion, anxiety- and depression-like behavior, and social behavior in healthy, VPA-treated and Xe-exposed young rats.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We have shown that in healthy animals Xe exposure resulted in acute and delayed decrease of exploratory motivation, partial decrease in risk-taking and depressive-like behavior as well as improved sensorimotor integration during the negative geotaxis test. Acute inhalations of Xe in VPA-exposed animals led to improvement in social behavior, decrease in exploratory motivation, and normalization of behavior in forced-swim test.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Behavioral modulatory effects of Xe are probably related to its generalized action on excitatory\/inhibitory balance within the CNS. Our data suggest that subanesthetic short-term exposures to Xe have beneficial effect on several behavioral modalities and deserves further investigation.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12967-019-02161-6","type":"journal-article","created":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T15:03:27Z","timestamp":1575385407000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Beneficial effects of xenon inhalation on behavioral changes in a valproic acid-induced model of autism in rats"],"prefix":"10.1186","volume":"17","author":[{"given":"A. P.","family":"Dobrovolsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. R.","family":"Gedzun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. I.","family":"Bogin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. E.","family":"Ichim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iu. A.","family":"Sukhanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. V.","family":"Malyshev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. A.","family":"Dubynin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,3]]},"reference":[{"key":"2161_CR1","doi-asserted-by":"publisher","first-page":"6897","DOI":"10.1523\/JNEUROSCI.1712-06.2006","volume":"26","author":"E DiCicco-Bloom","year":"2006","unstructured":"DiCicco-Bloom E, Lord C, Zwaigenbaum L, Courchesne E, Dager SR, Schmitz C, et al. The developmental neurobiology of autism spectrum disorder. J Neurosci. 2006;26:6897\u2013906. https:\/\/doi.org\/10.1523\/JNEUROSCI.1712-06.2006.","journal-title":"J Neurosci"},{"key":"2161_CR2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.conb.2007.01.009","volume":"17","author":"DH Geschwind","year":"2007","unstructured":"Geschwind DH, Levitt P. Autism spectrum disorders: developmental disconnection syndromes. Curr Opin Neurobiol. 2007;17:103\u201311. https:\/\/doi.org\/10.1016\/j.conb.2007.01.009.","journal-title":"Curr Opin Neurobiol"},{"key":"2161_CR3","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/mp.2014.98","volume":"20","author":"J Ellegood","year":"2015","unstructured":"Ellegood J, Anagnostou E, Babineau BA, Crawley JN, Lin L, Genestine M, et al. Clustering autism: using neuroanatomical differences in 26 mouse models to gain insight into the heterogeneity. Mol Psychiatry. 2015;20:118\u201325.","journal-title":"Mol Psychiatry"},{"key":"2161_CR4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1146\/annurev.publhealth.28.021406.144007","volume":"28","author":"CJ Newschaffer","year":"2007","unstructured":"Newschaffer CJ, Croen LA, Daniels J, Giarelli E, Grether JK, Levy SE, et al. The epidemiology of autism spectrum disorders. Annu Rev Public Health. 2007;28:235\u201358. https:\/\/doi.org\/10.1146\/annurev.publhealth.28.021406.144007.","journal-title":"Annu Rev Public Health"},{"key":"2161_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2018.07.001","author":"N Cattane","year":"2018","unstructured":"Cattane N, Richetto J, Cattaneo A. Prenatal exposure to environmental insults and enhanced risk of developing Schizophrenia and Autism Spectrum Disorder: focus on biological pathways and epigenetic mechanisms. Neurosci Biobehav Rev. 2018. https:\/\/doi.org\/10.1016\/j.neubiorev.2018.07.001.","journal-title":"Neurosci Biobehav Rev"},{"key":"2161_CR6","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.neuron.2015.07.033","volume":"87","author":"SB Nelson","year":"2015","unstructured":"Nelson SB, Valakh V. Excitatory\/inhibitory balance and circuit homeostasis in autism spectrum disorders. Neuron. 2015;87:684\u201398. https:\/\/doi.org\/10.1016\/j.neuron.2015.07.033.","journal-title":"Neuron"},{"key":"2161_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.coph.2014.10.007","volume":"20","author":"EJ Lee","year":"2015","unstructured":"Lee EJ, Choi SY, Kim E. NMDA receptor dysfunction in autism spectrum disorders. Curr Opin Pharmacol. 2015;20:8\u201313. https:\/\/doi.org\/10.1016\/j.coph.2014.10.007.","journal-title":"Curr Opin Pharmacol"},{"key":"2161_CR8","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00702-014-1216-0","volume":"121","author":"DC Rojas","year":"2014","unstructured":"Rojas DC. The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment. J Neural Transm. 2014;121:891\u2013905. https:\/\/doi.org\/10.1007\/s00702-014-1216-0.","journal-title":"J Neural Transm"},{"key":"2161_CR9","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.expneurol.2017.04.017","volume":"299","author":"C Nicolini","year":"2018","unstructured":"Nicolini C, Fahnestock M. The valproic acid-induced rodent model of autism. Exp Neurol. 2018;299:217\u201327. https:\/\/doi.org\/10.1016\/j.expneurol.2017.04.017.","journal-title":"Exp Neurol"},{"key":"2161_CR10","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1136\/JNNP-2012-304270","volume":"84","author":"RL Bromley","year":"2013","unstructured":"Bromley RL, Mawer GE, Briggs M, Cheyne C, Clayton-Smith J, Garc\u00eda-Fi\u00f1ana M, et al. The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry. 2013;84:637\u201343. https:\/\/doi.org\/10.1136\/JNNP-2012-304270.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2161_CR11","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.ejpn.2016.08.005","volume":"20","author":"R Riikonen","year":"2016","unstructured":"Riikonen R. Treatment of autistic spectrum disorder with insulin-like growth factors. Eur J Paediatr Neurol. 2016;20:816\u201323. https:\/\/doi.org\/10.1016\/j.ejpn.2016.08.005.","journal-title":"Eur J Paediatr Neurol"},{"key":"2161_CR12","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.ridd.2013.12.004","volume":"35","author":"S Deb","year":"2014","unstructured":"Deb S, Farmah BK, Arshad E, Deb T, Roy M, Unwin GL. The effectiveness of aripiprazole in the management of problem behaviour in people with intellectual disabilities, developmental disabilities and\/or autistic spectrum disorder\u2014a systematic review. Res Dev Disabil. 2014;35:711\u201325. https:\/\/doi.org\/10.1016\/j.ridd.2013.12.004.","journal-title":"Res Dev Disabil"},{"key":"2161_CR13","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.cpr.2009.01.003","volume":"29","author":"SW White","year":"2009","unstructured":"White SW, Oswald D, Ollendick T, Scahill L. Anxiety in children and adolescents with autism spectrum disorders. Clin Psychol Rev. 2009;29:216\u201329. https:\/\/doi.org\/10.1016\/j.cpr.2009.01.003.","journal-title":"Clin Psychol Rev"},{"key":"2161_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-27171-2","volume-title":"Handbook of assessment and diagnosis of autism spectrum disorder","year":"2016","unstructured":"Matson JL, editor. Handbook of assessment and diagnosis of autism spectrum disorder. Berlin: Springer; 2016. https:\/\/doi.org\/10.1007\/978-3-319-27171-2."},{"key":"2161_CR15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3389\/fnbeh.2017.00084","volume":"11","author":"S Nobusako","year":"2017","unstructured":"Nobusako S, Nishi Y, Nishi Y, Shuto T, Asano D, Osumi M, et al. Transcranial direct current stimulation of the temporoparietal junction and inferior frontal cortex improves imitation-inhibition and perspective-taking with no effect on the autism-spectrum quotient score. Front Behav Neurosci. 2017;11:84. https:\/\/doi.org\/10.3389\/fnbeh.2017.00084.","journal-title":"Front Behav Neurosci"},{"key":"2161_CR16","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/bja\/aeg232","volume":"91","author":"RD Sanders","year":"2003","unstructured":"Sanders RD, Franks NP, Maze M. Xenon: no stranger to anaesthesia. Br J Anaesth. 2003;91:709\u201317. https:\/\/doi.org\/10.1093\/bja\/aeg232.","journal-title":"Br J Anaesth"},{"key":"2161_CR17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S1474-4422(15)00347-6","volume":"15","author":"D Azzopardi","year":"2016","unstructured":"Azzopardi D, Robertson NJ, Bainbridge A, Cady E, Charles-Edwards G, Deierl A, et al. Moderate hypothermia within 6\u00a0h of birth plus inhaled xenon versus moderate hypothermia alone after birth asphyxia (TOBY-Xe): a proof-of-concept, open-label, randomised controlled trial. Lancet Neurol. 2016;15:145\u201353. https:\/\/doi.org\/10.1016\/S1474-4422(15)00347-6.","journal-title":"Lancet Neurol"},{"key":"2161_CR18","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.pneurobio.2014.01.001","volume":"115C","author":"J Deng","year":"2014","unstructured":"Deng J, Lei C, Chen Y, Fang Z, Yang Q, Zhang H, et al. Neuroprotective gases\u2014fantasy or reality for clinical use? Prog Neurobiol. 2014;115C:210\u201345. https:\/\/doi.org\/10.1016\/j.pneurobio.2014.01.001.","journal-title":"Prog Neurobiol"},{"key":"2161_CR19","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1097\/EJA.0b013e328357bfdd","volume":"29","author":"M Coburn","year":"2012","unstructured":"Coburn M, Sanders RD, Ma D, Fries M, Rex S, Magalon G, et al. Argon: the \u201clazy\u201d noble gas with organoprotective properties. Eur J Anaesthesiol. 2012;29:549\u201351. https:\/\/doi.org\/10.1097\/EJA.0b013e328357bfdd.","journal-title":"Eur J Anaesthesiol"},{"key":"2161_CR20","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1097\/WNR.0b013e328340d7f6","volume":"21","author":"B Bessi\u00e8re","year":"2010","unstructured":"Bessi\u00e8re B, Laboureyras E, Laulin JP, Simonnet G. Xenon prevents inflammation-induced delayed pain hypersensitivity in rats. NeuroReport. 2010;21:1167\u201371.","journal-title":"NeuroReport"},{"key":"2161_CR21","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/acer.12264","volume":"38","author":"V Vengeliene","year":"2014","unstructured":"Vengeliene V, Bessiere B, Pype J, Spanagel R. The effects of xenon and nitrous oxide gases on alcohol relapse. Alcohol Clin Exp Res. 2014;38:557\u201363. https:\/\/doi.org\/10.1111\/acer.12264.","journal-title":"Alcohol Clin Exp Res"},{"key":"2161_CR22","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1161\/01.STR.20.7.904","volume":"39","author":"C Hobbs","year":"2008","unstructured":"Hobbs C, Thoresen M, Tucker A, Aquilina K, Chakkarapani E, Dingley J. Xenon and hypothermia combine additively, offering long-term functional and histopathologic neuroprotection after neonatal hypoxia\/ischemia. Stroke. 2008;39:1307\u201313. https:\/\/doi.org\/10.1161\/01.STR.20.7.904.","journal-title":"Stroke"},{"key":"2161_CR23","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1097\/CCM.0b013e3182452164","volume":"40","author":"L Zhuang","year":"2012","unstructured":"Zhuang L, Yang T, Zhao H, Fidalgo AR, Vizcaychipi MP, Sanders RD, et al. The protective profile of argon, helium, and xenon in a model of neonatal asphyxia in rats. Crit Care Med. 2012;40:1724\u201330.","journal-title":"Crit Care Med"},{"key":"2161_CR24","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1096\/fj.07-9420com","volume":"22","author":"HN David","year":"2007","unstructured":"David HN, Haelewyn B, Rouillon C, Lecoq M, Chazalviel L, Apiou G, et al. Neuroprotective effects of xenon: a therapeutic window of opportunity in rats subjected to transient cerebral ischemia. FASEB J. 2007;22:1275\u201386. https:\/\/doi.org\/10.1096\/fj.07-9420com.","journal-title":"FASEB J"},{"key":"2161_CR25","doi-asserted-by":"publisher","first-page":"e106189","DOI":"10.1371\/journal.pone.0106189","volume":"9","author":"EG Meloni","year":"2014","unstructured":"Meloni EG, Gillis TE, Manoukian J, Kaufman MJ. Xenon impairs reconsolidation of fear memories in a rat model of Post-Traumatic Stress Disorder (PTSD). PLoS ONE. 2014;9:e106189. https:\/\/doi.org\/10.1371\/journal.pone.0106189.","journal-title":"PLoS ONE"},{"key":"2161_CR26","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/24525","volume":"396","author":"NP Franks","year":"1998","unstructured":"Franks NP, Dickinson R, De Sousa SLM, Hall AC, Lieb WR. How does xenon produce anaesthesia? Nature. 1998;396:324. https:\/\/doi.org\/10.1038\/24525.","journal-title":"Nature"},{"key":"2161_CR27","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1097\/00000542-200203000-00028","volume":"96","author":"T Suzuki","year":"2002","unstructured":"Suzuki T, Koyama H, Sugimoto M, Uchida I, Mashimo T. The diverse actions of volatile and gaseous anesthetics on human-cloned 5-hydroxytryptamine3receptors expressed in Xenopus oocytes. Anesthesiology. 2002;96:699\u2013704. https:\/\/doi.org\/10.1097\/00000542-200203000-00028.","journal-title":"Anesthesiology"},{"key":"2161_CR28","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1097\/00000542-200010000-00034","volume":"93","author":"T Yamakura","year":"2000","unstructured":"Yamakura T, Harris RA. Effects of gaseous anesthetics nitrous oxide and xenon on ligand-gated ion channels: comparison with isoflurane and ethanol. Anesthesiology. 2000;93:1095\u2013101. https:\/\/doi.org\/10.1097\/00000542-200010000-00034.","journal-title":"Anesthesiology"},{"key":"2161_CR29","doi-asserted-by":"crossref","first-page":"429","DOI":"10.55782\/ane-2009-1754","volume":"69","author":"HU Weigt","year":"2009","unstructured":"Weigt HU, Fohr KJ, Georgieff M, Georgieff EM, Senftleben U, Adolph O. Xenon blocks AMPA and NMDA receptor channels by different mechanisms. Acta Neurobiol Exp. 2009;69:429\u201340.","journal-title":"Acta Neurobiol Exp"},{"key":"2161_CR30","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1097\/ALN.0b013e31819dadc7","volume":"110","author":"C Bantel","year":"2009","unstructured":"Bantel C, Maze M, Trapp S. Neuronal preconditioning by inhalational anesthetics: evidence for the role of plasmalemmal adenosine triphosphate-sensitive potassium channels. Anesthesiology. 2009;110:986\u201395. https:\/\/doi.org\/10.1097\/ALN.0b013e31819dadc7.","journal-title":"Anesthesiology"},{"key":"2161_CR31","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1097\/ALN.0000000000000635","volume":"122","author":"C Mattusch","year":"2015","unstructured":"Mattusch C, Kratzer S, Buerge M, Kreuzer M, Engel T, Kopp C, et al. Impact of hyperpolarization-activated, cyclic nucleotide-gated cation channel Type 2 for the xenon-mediated anesthetic effect: evidence from in vitro and in vivo experiments. Anesthesiology. 2015;122:1047\u201359. https:\/\/doi.org\/10.1097\/ALN.0000000000000635.","journal-title":"Anesthesiology"},{"key":"2161_CR32","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12967-017-1237-1","volume":"15","author":"A Dobrovolsky","year":"2017","unstructured":"Dobrovolsky A, Ichim TE, Ma D, Kesari S, Bogin V. Xenon in the treatment of panic disorder: an open label study. J Transl Med. 2017;15:137. https:\/\/doi.org\/10.1186\/s12967-017-1237-1.","journal-title":"J Transl Med"},{"key":"2161_CR33","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.reprotox.2016.04.024","volume":"64","author":"Z Ergaz","year":"2016","unstructured":"Ergaz Z, Weinstein-Fudim L, Ornoy A. Genetic and non-genetic animal models for autism spectrum disorders (ASD). Reprod Toxicol. 2016;64:116\u201340. https:\/\/doi.org\/10.1016\/j.reprotox.2016.04.024.","journal-title":"Reprod Toxicol"},{"key":"2161_CR34","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3103\/S0096392515030074","volume":"70","author":"AV Malyshev","year":"2015","unstructured":"Malyshev AV, Abbasova KR, Averina OA, Solovieva LN, Gedzun VR, Gulyaev MV, et al. Fetal valproate syndrome as an experimental model of autism. Moscow Univ Biol Sci Bull. 2015;70:110\u20134. https:\/\/doi.org\/10.3103\/S0096392515030074.","journal-title":"Moscow Univ Biol Sci Bull"},{"key":"2161_CR35","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/0003-3472(75)90114-1","volume":"23","author":"J Altman","year":"1975","unstructured":"Altman J, Sudarshan K. Postnatal development of locomotion in the laboratory rat. Anim Behav. 1975;23:896\u2013920.","journal-title":"Anim Behav"},{"key":"2161_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ijdevneu.2019.06.007","volume":"78","author":"IA Sukhanova","year":"2019","unstructured":"Sukhanova IA, Sebentsova EA, Khukhareva DD, Vysokikh MY, Bezuglov VV, Bobrov MY, et al. Early-life N-arachidonoyl-dopamine exposure increases antioxidant capacity of the brain tissues and reduces functional deficits after neonatal hypoxia in rats. Int J Dev Neurosci. 2019;78:7\u201318. https:\/\/doi.org\/10.1016\/j.ijdevneu.2019.06.007.","journal-title":"Int J Dev Neurosci"},{"key":"2161_CR37","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1134\/s1819712418010154","volume":"12","author":"YA Sukhanova","year":"2018","unstructured":"Sukhanova YA, Volodina MA, Sebentsova EA, Glazova NY, Manchenko DM, Inozemtseva LS, et al. Long-term changes in behavior and the content of BDNF in the rat brain caused by neonatal isolation: the effects of an analog of ACTH(4\u201310) Semax. Neurochem J. 2018;12:53\u201363. https:\/\/doi.org\/10.1134\/s1819712418010154.","journal-title":"Neurochem J"},{"key":"2161_CR38","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1097\/ALN.0000000000000423","volume":"121","author":"H Gill","year":"2014","unstructured":"Gill H, Thoresen M, Bishop S, Smit E, Liu X, Walloe L, et al. Equipotent subanesthetic concentrations of sevoflurane and xenon preventing cold-stimulated vocalization of neonatal rats. Anesthesiology. 2014;121:1194\u2013202. https:\/\/doi.org\/10.1097\/ALN.0000000000000423.","journal-title":"Anesthesiology"},{"key":"2161_CR39","doi-asserted-by":"publisher","first-page":"e37020","DOI":"10.1371\/journal.pone.0037020","volume":"7","author":"T Yang","year":"2012","unstructured":"Yang T, Zhuang L, Rei Fidalgoo AM, Petrides E, Terrando N, Wu X, et al. Xenon and sevoflurane provide analgesia during labor and fetal brain protection in a perinatal rat model of hypoxia-ischemia. PLoS ONE. 2012;7:e37020. https:\/\/doi.org\/10.1371\/journal.pone.0037020.","journal-title":"PLoS ONE"},{"key":"2161_CR40","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/BF03016309","volume":"55","author":"D Cattano","year":"2008","unstructured":"Cattano D, Williamson P, Fukui K, Avidan M, Evers AS, Olney JW, et al. Potential of xenon to induce or to protect against neuroapoptosis in the developing mouse brain. Can J Anesth. 2008;55:429\u201336. https:\/\/doi.org\/10.1007\/BF03016309.","journal-title":"Can J Anesth"},{"key":"2161_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/mds.27404","volume":"00","author":"J Baufreton","year":"2018","unstructured":"Baufreton J, Milekovic T, Li Q, McGuire S, Mouraud EM, Porras G, et al. Inhaling xenon ameliorates l-dopa-induced dyskinesia in experimental Parkinsonism. Mov Disord. 2018;00:1\u201311. https:\/\/doi.org\/10.1002\/mds.27404.","journal-title":"Mov Disord"},{"key":"2161_CR42","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1213\/ane.0b013e3181618669","volume":"106","author":"J Dingley","year":"2008","unstructured":"Dingley J, Hobbs C, Ferguson J, Stone J, Thoresen M. Xenon\/hypothermia neuroprotection regimes in spontaneously breathing neonatal rats after hypoxic-ischemic insult: the respiratory and sedative effects. Anesth Analg. 2008;106:916\u201323.","journal-title":"Anesth Analg"},{"key":"2161_CR43","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13618-015-0029-z","volume":"5","author":"I Katz","year":"2015","unstructured":"Katz I, Murdock J, Palgen M, Pype J, Caillibotte G. Pharmacokinetic analysis of the chronic administration of the inert gases Xe and Ar using a physiological based model. Med Gas Res. 2015;5:8. https:\/\/doi.org\/10.1186\/s13618-015-0029-z.","journal-title":"Med Gas Res"},{"key":"2161_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-60761-303-9","volume-title":"Mood and anxiety related phenotypes in mice: characterization using behavioral tests","author":"TD Gould","year":"2009","unstructured":"Gould TD. Mood and anxiety related phenotypes in mice: characterization using behavioral tests. New York: Humana Press; 2009."},{"key":"2161_CR45","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1097\/01.anes.0000287061.77674.71","volume":"107","author":"R Dickinson","year":"2007","unstructured":"Dickinson R, Peterson BK, Banks P, Simillis C, Martin JCS, Valenzuela CA, et al. Competitive inhibition at the glycine site of the N-methyl-d-aspartate receptor by the anesthetics xenon and isoflurane: evidence from molecular modeling and electrophysiology. Anesthesiology. 2007;107:756\u201367. https:\/\/doi.org\/10.1097\/01.anes.0000287061.77674.71.","journal-title":"Anesthesiology"},{"key":"2161_CR46","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1124\/mol.65.2.443","volume":"65","author":"M Gruss","year":"2004","unstructured":"Gruss M, Bushell TJ, Bright DP, Lieb WR, Mathie A, Franks NP. Two-pore-domain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol Pharmacol. 2004;65:443\u201352. https:\/\/doi.org\/10.1124\/mol.65.2.443.","journal-title":"Mol Pharmacol"},{"key":"2161_CR47","doi-asserted-by":"publisher","first-page":"13501","DOI":"10.1073\/pnas.0704391104","volume":"104","author":"T Rinaldi","year":"2007","unstructured":"Rinaldi T, Kulangara K, Antoniello K, Markram H. Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid. Proc Natl Acad Sci. 2007;104:13501\u20136. https:\/\/doi.org\/10.1073\/pnas.0704391104.","journal-title":"Proc Natl Acad Sci"},{"key":"2161_CR48","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/neuro.04.004.2008","volume":"2","author":"T Rinaldi","year":"2008","unstructured":"Rinaldi T, Perrodin C, Markram H. Hyper-connectivity and hyper-plasticity in the medial prefrontal cortex in the valproic acid animal model of autism. Front Neural Circuits. 2008;2:4. https:\/\/doi.org\/10.3389\/neuro.04.004.2008.","journal-title":"Front Neural Circuits"},{"key":"2161_CR49","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.ntt.2005.06.005","volume":"27","author":"BA Motz","year":"2005","unstructured":"Motz BA, Alberts JR. The validity and utility of geotaxis in young rodents. Neurotoxicol Teratol. 2005;27:529\u201333.","journal-title":"Neurotoxicol Teratol"},{"key":"2161_CR50","doi-asserted-by":"publisher","first-page":"3536","DOI":"10.1002\/jnr.21812","volume":"86","author":"L-W Fan","year":"2008","unstructured":"Fan L-W, Chen R-F, Mitchell HJ, Lin RCS, Simpson KL, Rhodes PG, et al. Alpha-phenyl-n-tert-butyl-nitrone attenuates lipopolysaccharide-induced brain injury and improves neurological reflexes and early sensorimotor behavioral performance in juvenile rats. J Neurosci Res. 2008;86:3536\u201347. https:\/\/doi.org\/10.1002\/jnr.21812.","journal-title":"J Neurosci Res"},{"key":"2161_CR51","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/sj.npp.1300518","volume":"30","author":"T Schneider","year":"2005","unstructured":"Schneider T, Przew\u0142ocki R. Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology. 2005;30:80\u20139. https:\/\/doi.org\/10.1038\/sj.npp.1300518.","journal-title":"Neuropsychopharmacology."},{"key":"2161_CR52","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1159\/000336646","volume":"34","author":"S Reynolds","year":"2012","unstructured":"Reynolds S, Millette A, Devine DP. Sensory and motor characterization in the postnatal valproate rat model of autism. Dev Neurosci. 2012;34:258\u201367. https:\/\/doi.org\/10.1159\/000336646.","journal-title":"Dev Neurosci"},{"key":"2161_CR53","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.bbr.2014.04.045","volume":"270","author":"B Pragnya","year":"2014","unstructured":"Pragnya B, Kameshwari JSL, Veeresh B. Ameliorating effect of piperine on behavioral abnormalities and oxidative markers in sodium valproate induced autism in BALB\/C mice. Behav Brain Res. 2014;270:86\u201394. https:\/\/doi.org\/10.1016\/j.bbr.2014.04.045.","journal-title":"Behav Brain Res"},{"key":"2161_CR54","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s10803-006-0117-y","volume":"36","author":"GC Wagner","year":"2006","unstructured":"Wagner GC, Reuhl KR, Cheh M, McRae P, Halladay AK. A new neurobehavioral model of autism in mice: pre- and postnatal exposure to sodium valproate. J Autism Dev Disord. 2006;36:779\u201393.","journal-title":"J Autism Dev Disord"},{"key":"2161_CR55","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1134\/S0012496613030046","volume":"450","author":"AV Malyshev","year":"2013","unstructured":"Malyshev AV, Razumkina EV, Dubynin VA, Myasoedov NF. Semax corrects brain dysfunction caused by prenatal introduction of valproic acid. Dokl Biol Sci. 2013;450:126\u20139. https:\/\/doi.org\/10.1134\/S0012496613030046.","journal-title":"Dokl Biol Sci"},{"key":"2161_CR56","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.neuroscience.2013.03.030","volume":"241","author":"ME Bringas","year":"2013","unstructured":"Bringas ME, Carvajal-Flores FN, L\u00f3pez-Ram\u00edrez TA, Atzori M, Flores G. Rearrangement of the dendritic morphology in limbic regions and altered exploratory behavior in a rat model of autism spectrum disorder. Neuroscience. 2013;241:170\u201387.","journal-title":"Neuroscience"},{"key":"2161_CR57","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.neuropharm.2016.09.014","volume":"113","author":"JW Kim","year":"2017","unstructured":"Kim JW, Seung H, Kim KC, Gonzales ELT, Oh HA, Yang SM, et al. Agmatine rescues autistic behaviors in the valproic acid-induced animal model of autism. Neuropharmacology. 2017;113:71\u201381. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.09.014.","journal-title":"Neuropharmacology"},{"key":"2161_CR58","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/sj.npp.1301453","volume":"33","author":"K Markram","year":"2008","unstructured":"Markram K, Rinaldi T, La Mendola D, Sandi C, Markram H. Abnormal fear conditioning and amygdala processing in an animal model of autism. Neuropsychopharmacology. 2008;33:901\u201312. https:\/\/doi.org\/10.1038\/sj.npp.1301453.","journal-title":"Neuropsychopharmacology"},{"key":"2161_CR59","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1007\/s10803-012-1677-7","volume":"43","author":"E Hanson","year":"2013","unstructured":"Hanson E, Cerban BM, Slater CM, Caccamo LM, Bacic J, Chan E. Brief report: prevalence of attention deficit\/hyperactivity disorder among individuals with an autism spectrum disorder. J Autism Dev Disord. 2013;43:1459\u201364. https:\/\/doi.org\/10.1007\/s10803-012-1677-7.","journal-title":"J Autism Dev Disord"},{"key":"2161_CR60","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s10567-011-0097-0","volume":"14","author":"FJA van Steensel","year":"2011","unstructured":"van Steensel FJA, B\u00f6gels SM, Perrin S. Anxiety disorders in children and adolescents with autistic spectrum disorders: a meta-analysis. Clin Child Fam Psychol Rev. 2011;14:302\u201317. https:\/\/doi.org\/10.1007\/s10567-011-0097-0.","journal-title":"Clin Child Fam Psychol Rev"},{"key":"2161_CR61","doi-asserted-by":"publisher","first-page":"e902","DOI":"10.1038\/tp.2016.182","volume":"6","author":"M Servadio","year":"2016","unstructured":"Servadio M, Melancia F, Manduca A, Di Masi A, Schiavi S, Cartocci V, et al. Targeting anandamide metabolism rescues core and associated autistic-like symptoms in rats prenatally exposed to valproic acid. Transl Psychiatry. 2016;6:e902. https:\/\/doi.org\/10.1038\/tp.2016.182.","journal-title":"Transl Psychiatry"},{"key":"2161_CR62","doi-asserted-by":"publisher","first-page":"6774","DOI":"10.1007\/s12035-015-9600-9","volume":"53","author":"CY Wang","year":"2016","unstructured":"Wang CY, Cheng CW, Wang WH, Chen PS, Tzeng SF. Postnatal stress induced by injection with valproate leads to developing emotional disorders along with molecular and cellular changes in the hippocampus and amygdala. Mol Neurobiol. 2016;53:6774\u201385. https:\/\/doi.org\/10.1007\/s12035-015-9600-9.","journal-title":"Mol Neurobiol"},{"key":"2161_CR63","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.nbd.2015.05.006","volume":"80","author":"NFM Olde Loohuis","year":"2015","unstructured":"Olde Loohuis NFM, Kole K, Glennon JC, Karel P, Van der Borg G, Van Gemert Y, et al. Elevated microRNA-181c and microRNA-30d levels in the enlarged amygdala of the valproic acid rat model of autism. Neurobiol Dis. 2015;80:42\u201353. https:\/\/doi.org\/10.1016\/j.nbd.2015.05.006.","journal-title":"Neurobiol Dis"},{"key":"2161_CR64","doi-asserted-by":"publisher","first-page":"50","DOI":"10.15360\/1813-9779-2014-2-50-56","volume":"10","author":"NV Stryapko","year":"2014","unstructured":"Stryapko NV, Sazontova TG, Potievskaya VI, Khairullina AA, Vdovina IB, Kulikov AN, et al. Adaptation effect of repeated xenon application. Gen Reanimatol. 2014;10:50. https:\/\/doi.org\/10.15360\/1813-9779-2014-2-50-56.","journal-title":"Gen Reanimatol"},{"key":"2161_CR65","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.neulet.2009.12.054","volume":"470","author":"D Dufour-Rainfray","year":"2010","unstructured":"Dufour-Rainfray D, Vourc\u2019h P, Le Guisquet AM, Garreau L, Ternant D, Bodard S, et al. Behavior and serotonergic disorders in rats exposed prenatally to valproate: a model for autism. Neurosci Lett. 2010;470:55\u20139. https:\/\/doi.org\/10.1016\/j.neulet.2009.12.054.","journal-title":"Neurosci Lett"},{"key":"2161_CR66","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1017\/S1461145711001714","volume":"16","author":"S Kataoka","year":"2013","unstructured":"Kataoka S, Takuma K, Hara Y, Maeda Y, Ago Y, Matsuda T. Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid. Int J Neuropsychopharmacol. 2013;16:91\u2013103. https:\/\/doi.org\/10.1017\/S1461145711001714.","journal-title":"Int J Neuropsychopharmacol"},{"key":"2161_CR67","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1016\/j.bbadis.2014.08.009","volume":"1842","author":"RA Hill","year":"2014","unstructured":"Hill RA, Kiss Von Soly S, Ratnayake U, Klug M, Binder MD, Hannan AJ, et al. Long-term effects of combined neonatal and adolescent stress on brain-derived neurotrophic factor and dopamine receptor expression in the rat forebrain. Biochim Biophys Acta Mol Basis Dis. 2014;1842:2126\u201335. https:\/\/doi.org\/10.1016\/j.bbadis.2014.08.009.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2161_CR68","doi-asserted-by":"publisher","first-page":"863-IN4","DOI":"10.1016\/0278-5846(90)90073-P","volume":"14","author":"AP West","year":"1990","unstructured":"West AP. Neurobehavioral studies of forced swimming: the role of learning and memory in the forced swim test. Prog Neuro-Psychopharmacol Biol Psychiatry. 1990;14:863-IN4.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"2161_CR69","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1134\/S1819712416040127","volume":"10","author":"IA Sukhanova","year":"2016","unstructured":"Sukhanova IA, Sebentsova EA, Levitskaya NG. The acute and delayed effects of perinatal hypoxic brain damage in children and in model experiments with rodents. Neurochem J. 2016;10:258\u201372. https:\/\/doi.org\/10.1134\/S1819712416040127.","journal-title":"Neurochem J"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-019-02161-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-019-02161-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-019-02161-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T02:36:46Z","timestamp":1722134206000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-019-02161-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2161"],"URL":"https:\/\/doi.org\/10.1186\/s12967-019-02161-6","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"24 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All efforts were made to minimize the number of animals used. All protocols and procedures were conducted in accordance with Moscow State University\u2019s Committee on Biomedical Research Ethics.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Dobrovolsky is the co-founder of Nobilis Therapeutics, Inc., a company that is developing treatments for psychiatric disorders using noble gas xenon. Dr. Bogin is the co-founder and CEO of Nobilis Therapeutics, Inc., a company that is developing treatments for psychiatric disorders using noble gas xenon. Dr. Ma is the member of the scientific advisory board of Nobilis Therapeutics.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"400"}}